Peptide Development Lab Expansion at Flatiron Park
Sector: Manufacturing (Industrial) • Location: Boulder, Colorado, United States
Source: CHEManager
CordenPharma Colorado has leased a newly completed, purpose-built peptide development lab at Flatiron Park in Boulder, Colorado. The 64,000 square feet LEED Gold-certified facility supports advanced peptide Active Pharmaceutical Ingredient (API) production from development through commercialization, featuring robust power capacity, adaptable lab grids, advanced mechanical and utility systems, and
- Status
- Closed
- Sector
- Manufacturing (Industrial), Power Transmission, Power Generation (CCGT)
- Location
- Boulder, Colorado, United States of America
- Updated
- 22 Jul 2026
- Source
- CHEManager
ConstructChat
Ask ConstructChat about Peptide Development Lab Expansion at Flatiron Park
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | leased |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | CordenPharma Colorado has leased a newly completed, purpose-built peptide development lab at Flatiron Park in Boulder, Colorado. The 64,000 square feet LEED Gold-certified facility supports advanced peptide Active Pharmaceutical Ingredient (API) production from development through commercialization, featuring robust power capacity, adaptable lab grids, advanced mechanical and utility systems, and efficient waste disposal. The lab expansion enables integration with CordenPharma's existing large-scale peptide manufacturing facility and supports their global network. |
Original sector | Life Science |
Location
Country | United States of America (USA) |
State | Colorado |
City | Boulder |
Source
Source | CHEManager |
URL |
More Details
Record type | Project |
Sector | Manufacturing (Industrial), Power Transmission, Power Generation (CCGT) |
Article published date | 2026-03-22 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
